164 related articles for article (PubMed ID: 38584112)
1. [Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease].
Yuan XW; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2024 Mar; 32(3):262-267. PubMed ID: 38584112
[TBL] [Abstract][Full Text] [Related]
2. Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease.
Zhao S; Guo Y; Yin X
Front Biosci (Landmark Ed); 2023 Dec; 28(12):332. PubMed ID: 38179745
[TBL] [Abstract][Full Text] [Related]
3. Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies.
Zhang H; Zhang E; Hu H
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829889
[TBL] [Abstract][Full Text] [Related]
4. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.
Gao G; Xie Z; Li EW; Yuan Y; Fu Y; Wang P; Zhang X; Qiao Y; Xu J; Hölscher C; Wang H; Zhang Z
J Nat Med; 2021 Jun; 75(3):540-552. PubMed ID: 33590347
[TBL] [Abstract][Full Text] [Related]
5. Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis.
Yuan X; Li L; Zhang Y; Ai R; Li D; Dou Y; Hou M; Zhao D; Zhao S; Nan Y
Lipids Health Dis; 2023 Jul; 22(1):99. PubMed ID: 37422643
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?
Feng G; Byrne CD; Targher G; Wang F; Zheng MH
Liver Int; 2022 Jul; 42(7):1496-1502. PubMed ID: 35007392
[TBL] [Abstract][Full Text] [Related]
7. An overview of ferroptosis in non-alcoholic fatty liver disease.
Wang S; Liu Z; Geng J; Li L; Feng X
Biomed Pharmacother; 2022 Sep; 153():113374. PubMed ID: 35834990
[TBL] [Abstract][Full Text] [Related]
8. Heme oxygenase-1 modulates ferroptosis by fine-tuning levels of intracellular iron and reactive oxygen species of macrophages in response to
Ma C; Wu X; Zhang X; Liu X; Deng G
Front Cell Infect Microbiol; 2022; 12():1004148. PubMed ID: 36211962
[TBL] [Abstract][Full Text] [Related]
9. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.
Yang Y; Chen J; Gao Q; Shan X; Wang J; Lv Z
Toxicology; 2020 Dec; 445():152599. PubMed ID: 32976958
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis.
Guo T; Yan W; Cui X; Liu N; Wei X; Sun Y; Fan K; Liu J; Zhu Y; Wang Z; Zhang Y; Chen L
Mol Med; 2023 Sep; 29(1):132. PubMed ID: 37770820
[TBL] [Abstract][Full Text] [Related]
11. [Application of heme oxygenase 1 in the diagnosis of non-alcoholic fatty liver disease].
Yuan XW; Li DD; Liu LD; Zhang Y; Zhao W; Cui LY; Yang Y; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):291-297. PubMed ID: 31082341
[No Abstract] [Full Text] [Related]
12. Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis.
Wu Q; Chen Z; Ding Y; Tang Y; Cheng Y
Front Nutr; 2022; 9():1033129. PubMed ID: 36330148
[TBL] [Abstract][Full Text] [Related]
13. Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases.
Ma C; Han L; Zhu Z; Heng Pang C; Pan G
Biochem Pharmacol; 2022 Nov; 205():115242. PubMed ID: 36084708
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of ferroptosis-related genes and immune cell infiltration in non-alcoholic fatty liver disease.
Zhang H; Axinbai M; Zhao Y; Wei J; Qu T; Kong J; He Y; Zhang L
Eur J Med Res; 2023 Dec; 28(1):605. PubMed ID: 38115130
[TBL] [Abstract][Full Text] [Related]
15. Melatonin targets ferroptosis through bimodal alteration of redox environment and cellular pathways in NAFLD model.
Saha M; Das S; Manna K; Saha KD
Biosci Rep; 2023 Oct; 43(10):. PubMed ID: 37728565
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications.
Cheng Z; Chu H; Zhu Q; Yang L
Front Nutr; 2023; 10():1090338. PubMed ID: 36992907
[TBL] [Abstract][Full Text] [Related]
17. [Value of constructing a non-invasive diagnostic model based on serum heme oxygenase-1 and glucose regulatory protein 78 for non-alcoholic fatty liver disease].
Cao JC; Zhang HK; Liu CM; Zhao SS; Nan YM; Li DD
Zhonghua Gan Zang Bing Za Zhi; 2024 Mar; 32(3):228-234. PubMed ID: 38584104
[No Abstract] [Full Text] [Related]
18. Ferroptosis as a target for protection against cardiomyopathy.
Fang X; Wang H; Han D; Xie E; Yang X; Wei J; Gu S; Gao F; Zhu N; Yin X; Cheng Q; Zhang P; Dai W; Chen J; Yang F; Yang HT; Linkermann A; Gu W; Min J; Wang F
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2672-2680. PubMed ID: 30692261
[TBL] [Abstract][Full Text] [Related]
19. Natural Product Heme Oxygenase Inducers as Treatment for Nonalcoholic Fatty Liver Disease.
Stec DE; Hinds TD
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327438
[TBL] [Abstract][Full Text] [Related]
20. The Gut Microbiome and Ferroptosis in MAFLD.
Ji J; Wu L; Wei J; Wu J; Guo C
J Clin Transl Hepatol; 2023 Feb; 11(1):174-187. PubMed ID: 36406312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
